Gilead Sciences | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 350.71B 19.93B 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Alnylam Pharmaceuticals USD 33.46B 1.67B 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
Gilead Sciences USD 128.54B 11.15B 2025-05
GlaxoSmithKline GBP 60.04B 311.52M 2025-05
Glaxosmithkline USD 69.83B 14.22B 2024-12
Incyte USD 14.04B 2.32B 2025-05
J&J USD 373.47B 26.18B 2025-05
Merck USD 208.29B 17.59B 2025-05
Moderna USD 10.66B 302M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 135.11B 8.61B 2025-05
PTC Therapeutics USD 3.09B 417M 2025-05
Regeneron Pharmaceuticals USD 66.28B 3.05B 2025-05
Sanofi EUR 120.97B 4.87B 2025-05
Sarepta Therapeutics USD 5.85B 5.93B 2025-05
United Therapeutics USD 13.82B 77M 2025-05
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



Gilead Sciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.